Graves Disease
📧 Sign up to get email alerts when something new happens for Graves Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: Effects of Vitamin D Supplementation on Muscle Function Among Grave's Disease Patients [NA]
This clinical trial update reports completion of a study evaluating whether vitamin D supplementation improves muscle function in patients w…
-
CLINICAL_TRIALS research · 2024-05-30Clinical Trial Update: A Prospective Evaluation of Radiofrequency Ablation in the Treatment of Relapsed Graves' Disease. [NA]
A prospective evaluation of radiofrequency ablation for treating relapsed Graves' disease, with the trial currently active but not recruitin…
-
CLINICAL_TRIALS research · 2024-05-28Clinical Trial Update: To Investigate the Effect of 2019 Novel Coronavirus Infection on the Condition of Patients With Hyperthyroidism
This clinical trial investigates how COVID-19 affects people with Graves' disease (hyperthyroidism); the study status is currently unknown.
-
CLINICAL_TRIALS research · 2024-05-23Clinical Trial Update: Graves' Disease Induced by Epstein-Barr Virus Lytic Reactivation
This clinical trial update examines Graves' disease potentially triggered by Epstein-Barr Virus lytic reactivation, with the study status no…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Methimazole in Graves' Disease - Comparing the Computer-aided Treatment DigiThy Versus Usual Care [NA]
This clinical trial update describes a study evaluating methimazole for Graves' disease comparing the DigiThy computer-aided treatment to us…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: Preoperative Preparation With Lugol Solution in Patients With Graves-Basedow Disease. [Phase 4]
Phase 4 clinical trial evaluating preoperative Lugol solution in patients with Graves-Basedow disease (hyperthyroidism).
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Graves' Disease Remission Study: MycoMeth Combo [Phase 2, Phase 3]
Phase 2/3 clinical trial update for MycoMeth Combo in Graves' disease currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease [Phase 4]
A Phase 4 clinical trial update assessing how different treatment schemes affect regulation and relapse in Graves' disease, currently recrui…
-
FDA approval · 2023-09-25FDA Approved: METHIMAZOLE — Original Application (Bionpharma Inc.)
The FDA approved an original application for a generic Methimazole from Bionpharma Inc., adding a generic version of the antithyroid medicat…
-
CLINICAL_TRIALS trial_result · 2021-11-17Clinical Trial Update: Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy [Phase 2]
Phase 2 clinical trial update evaluating doxycycline for mild thyroid-associated ophthalmopathy (Graves-related eye disease).
-
CLINICAL_TRIALS trial_result · 2021-11-12Clinical Trial Update: Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis [Phase 3]
Phase 3 trial update examining the effect of hyperthyroidism and its treatment on an early marker of atherosclerosis in Graves' disease.
-
FDA approval · 2021-10-20FDA Approved: METHIMAZOLE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approves a supplemental application from Rising Pharma Holdings, Inc. for a generic methimazole product, expanding access to the labeled…
-
FDA approval · 2021-10-20FDA Approved: METHIMAZOLE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application from Strides Pharma Science Limited for methimazole, a generic antithyroid medication. The appro…
-
FDA approval · 2021-03-18FDA Approved: PROPYLTHIOURACIL — Supplemental Application (QUAGEN PHARMACEUTICALS LLC)
FDA approved a supplemental application for Propylthiouracil from Quagen Pharmaceuticals LLC under the ANDA process.
-
CLINICAL_TRIALS trial_result · 2020-03-27Clinical Trial Update: Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment [Phase 4]
Phase 4 diagnostic accuracy study evaluating indocyanine green for assessing parathyroid perfusion in thyroid surgery is completed.
-
CLINICAL_TRIALS trial_result · 2020-02-20Clinical Trial Update: Effects Of Oral Alfacalcidol On Maturation Of Dendritic Cells In Graves' Disease Patients [Phase 2]
Phase 2 trial evaluating oral alfacalcidol and its effects on maturation of dendritic cells in Graves' disease.
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: Early Levothyroxine Post Radioactive Iodine [Phase 2, Phase 3]
Clinical trial update on early levothyroxine after radioactive iodine for Graves' disease reported completion and results posting.
-
CLINICAL_TRIALS trial_result · 2019-09-23Clinical Trial Update: Bupivacaine Injection of Eye Muscles to Treat Strabismus [Phase 2, Phase 3]
Clinical trials are evaluating bupivacaine injections into eye muscles for treating strabismus across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2019-06-14Clinical Trial Update: ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy [Phase 1]
Phase 1 clinical trial update for ATX-GD-59 in Graves disease patients not treated with anti-thyroid therapy has completed with results post…
-
FDA approval · 2019-01-23FDA Approved: METHIMAZOLE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for methimazole from Rising Pharma Holdings, expanding the availability of this generic treatmen…
-
FDA approval · 2019-01-18FDA Approved: METHIMAZOLE — Supplemental Application (Strides Pharma Science Limited)
FDA approves a supplemental application for Strides Pharma Science Limited's methimazole, updating the already approved product under an AND…
-
FDA approval · 2019-01-18FDA Approved: METHIMAZOLE — Supplemental Application (NORTHSTAR RX LLC)
The FDA approved a supplemental application for methimazole submitted by NorthStar RX LLC.
-
FDA approval · 2019-01-18FDA Approved: METHIMAZOLE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for Methimazole submitted by Chartwell RX, LLC (ANDA).
-
FDA label_change · 2019-01-18FDA Approved: METHIMAZOLE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for methimazole from Upsher-Smith Laboratories, updating the labeling for the antithyroid medica…
-
FDA approval · 2018-09-19FDA Approved: PROPYLTHIOURACIL — Supplemental Application (Endo USA, Inc.)
FDA approves a supplemental application for Propylthiouracil from Endo USA, Inc.